AZD5363 Catalog No.:M10096-10 RPR 102341 is structurally similar

RPR 102341 is structurally similar to the fluoroquinolone class of antibiotics

It is converted by esterases to the active drug aciclovir

respectively) and in human

Formula: C25H29FN4O5

is an inhibitor of epidermal growth factor (EGF) receptor kinase with an IC50 value of 460 µM in the human epidermoid carcinoma cell line A431

AZD5363 Catalog No.:M10096-10 RPR 102341 is structurally similarAZD5363, also known as Capivasertib, is an orally available inhibitor of the serine threonine protein kinase AKT (protein kinase B) with potential antineoplastic activity. AKT inhibitor AZD5363 binds to and inhibits all AKT isoforms. Inhibition of AKT prevents the phosphorylation of AKT substrates that mediate cellular processes, such as cell division, apoptosis, and glucose and fatty acid metabolism. A wide range of solid and hematological